Abstract
We reviewed follow-up data on 32 patients with orbital rhabdomyosarcoma, who were treated with external beam radiation with and without adjunctive chemotherapy between 1960 and 1992. Patients were followed up from five to eight years. Of the 32 patients, six (19%) had best-corrected visual acuity of 20/70 or better; five patients (15%) had best-corrected visual acuity of light perception to 20/300; 21 patients (66%) had no light perception. The reported long-term visual acuities should be factored in the equation for selecting treatment for patients with orbital rhabdomyosarcoma.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
